nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—CYP2C8—Levothyroxine—hypothyroidism	0.125	0.227	CbGbCtD
Ketamine—CYP2C8—Liotrix—hypothyroidism	0.122	0.222	CbGbCtD
Ketamine—ABCB1—Liothyronine—hypothyroidism	0.0845	0.154	CbGbCtD
Ketamine—ABCB1—Levothyroxine—hypothyroidism	0.0845	0.154	CbGbCtD
Ketamine—ABCB1—Liotrix—hypothyroidism	0.0825	0.15	CbGbCtD
Ketamine—CYP3A4—Levothyroxine—hypothyroidism	0.0506	0.0923	CbGbCtD
Ketamine—Muscle twitching—Liothyronine—hypothyroidism	0.0132	0.183	CcSEcCtD
Ketamine—GRIN2C—nerve—hypothyroidism	0.0126	0.0865	CbGeAlD
Ketamine—GRIN2B—nerve—hypothyroidism	0.01	0.0684	CbGeAlD
Ketamine—TACR1—nerve—hypothyroidism	0.00958	0.0656	CbGeAlD
Ketamine—GRIN2A—nerve—hypothyroidism	0.00874	0.0598	CbGeAlD
Ketamine—GRIN3B—testis—hypothyroidism	0.00603	0.0413	CbGeAlD
Ketamine—Arrhythmia—Liothyronine—hypothyroidism	0.0058	0.0804	CcSEcCtD
Ketamine—OPRM1—nerve—hypothyroidism	0.00531	0.0363	CbGeAlD
Ketamine—GRIN2C—adrenal cortex—hypothyroidism	0.00485	0.0332	CbGeAlD
Ketamine—Muscle twitching—Liotrix—hypothyroidism	0.00475	0.066	CcSEcCtD
Ketamine—Hypotension—Liothyronine—hypothyroidism	0.00431	0.0598	CcSEcCtD
Ketamine—CYP2C9—urine—hypothyroidism	0.00411	0.0281	CbGeAlD
Ketamine—SLC6A2—nerve—hypothyroidism	0.00389	0.0266	CbGeAlD
Ketamine—DRD2—nerve—hypothyroidism	0.00354	0.0242	CbGeAlD
Ketamine—GRIN2C—thyroid gland—hypothyroidism	0.00338	0.0231	CbGeAlD
Ketamine—GRIN2A—heart—hypothyroidism	0.00324	0.0222	CbGeAlD
Ketamine—CYP3A4—urine—hypothyroidism	0.00314	0.0215	CbGeAlD
Ketamine—GRIN2C—testis—hypothyroidism	0.0029	0.0198	CbGeAlD
Ketamine—Arrhythmia—Levothyroxine—hypothyroidism	0.00285	0.0395	CcSEcCtD
Ketamine—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00285	0.0395	CcSEcCtD
Ketamine—GRIN2D—testis—hypothyroidism	0.00269	0.0184	CbGeAlD
Ketamine—GRIN2C—cerebellum—hypothyroidism	0.00268	0.0183	CbGeAlD
Ketamine—TACR1—adrenal gland—hypothyroidism	0.00266	0.0182	CbGeAlD
Ketamine—TACR1—blood—hypothyroidism	0.00266	0.0182	CbGeAlD
Ketamine—GRIN3A—testis—hypothyroidism	0.00253	0.0173	CbGeAlD
Ketamine—GRIN2D—cerebellum—hypothyroidism	0.00249	0.017	CbGeAlD
Ketamine—GRIN2A—adrenal gland—hypothyroidism	0.00242	0.0166	CbGeAlD
Ketamine—Convulsion—Dextrothyroxine—hypothyroidism	0.0024	0.0333	CcSEcCtD
Ketamine—Convulsion—Levothyroxine—hypothyroidism	0.0024	0.0333	CcSEcCtD
Ketamine—Shock—Levothyroxine—hypothyroidism	0.00223	0.0309	CcSEcCtD
Ketamine—Shock—Dextrothyroxine—hypothyroidism	0.00223	0.0309	CcSEcCtD
Ketamine—GRIN1—cerebellum—hypothyroidism	0.00222	0.0152	CbGeAlD
Ketamine—TACR1—testis—hypothyroidism	0.0022	0.015	CbGeAlD
Ketamine—GRIN2B—cerebellum—hypothyroidism	0.00212	0.0145	CbGeAlD
Ketamine—Arrhythmia—Liotrix—hypothyroidism	0.00209	0.0291	CcSEcCtD
Ketamine—GRIN2A—testis—hypothyroidism	0.002	0.0137	CbGeAlD
Ketamine—Vision blurred—Liotrix—hypothyroidism	0.00192	0.0267	CcSEcCtD
Ketamine—GRIN2A—cerebellum—hypothyroidism	0.00185	0.0127	CbGeAlD
Ketamine—Convulsion—Liotrix—hypothyroidism	0.00177	0.0245	CcSEcCtD
Ketamine—Anaphylactic shock—Liotrix—hypothyroidism	0.00167	0.0231	CcSEcCtD
Ketamine—Shock—Liotrix—hypothyroidism	0.00164	0.0227	CcSEcCtD
Ketamine—Anorexia—Liotrix—hypothyroidism	0.00159	0.022	CcSEcCtD
Ketamine—OPRK1—cerebellum—hypothyroidism	0.00158	0.0108	CbGeAlD
Ketamine—Hypotension—Liotrix—hypothyroidism	0.00156	0.0216	CcSEcCtD
Ketamine—OPRM1—blood—hypothyroidism	0.00147	0.0101	CbGeAlD
Ketamine—Decreased appetite—Liotrix—hypothyroidism	0.00145	0.0201	CcSEcCtD
Ketamine—Vomiting—Levothyroxine—hypothyroidism	0.00144	0.02	CcSEcCtD
Ketamine—Vomiting—Dextrothyroxine—hypothyroidism	0.00144	0.02	CcSEcCtD
Ketamine—Rash—Dextrothyroxine—hypothyroidism	0.00143	0.0198	CcSEcCtD
Ketamine—Rash—Levothyroxine—hypothyroidism	0.00143	0.0198	CcSEcCtD
Ketamine—Dermatitis—Dextrothyroxine—hypothyroidism	0.00143	0.0198	CcSEcCtD
Ketamine—Dermatitis—Levothyroxine—hypothyroidism	0.00143	0.0198	CcSEcCtD
Ketamine—Nausea—Dextrothyroxine—hypothyroidism	0.00134	0.0187	CcSEcCtD
Ketamine—Nausea—Levothyroxine—hypothyroidism	0.00134	0.0187	CcSEcCtD
Ketamine—SLC6A2—gonad—hypothyroidism	0.00124	0.00846	CbGeAlD
Ketamine—OPRM1—testis—hypothyroidism	0.00122	0.00833	CbGeAlD
Ketamine—CYP2B6—adrenal cortex—hypothyroidism	0.0011	0.00753	CbGeAlD
Ketamine—DRD2—pituitary gland—hypothyroidism	0.0011	0.00752	CbGeAlD
Ketamine—SLC6A2—adrenal gland—hypothyroidism	0.00108	0.00737	CbGeAlD
Ketamine—CYP2B6—heart—hypothyroidism	0.00106	0.00728	CbGeAlD
Ketamine—Vomiting—Liotrix—hypothyroidism	0.00106	0.0147	CcSEcCtD
Ketamine—CYP2C9—heart—hypothyroidism	0.00105	0.00721	CbGeAlD
Ketamine—Rash—Liotrix—hypothyroidism	0.00105	0.0146	CcSEcCtD
Ketamine—Dermatitis—Liotrix—hypothyroidism	0.00105	0.0146	CcSEcCtD
Ketamine—CYP2B6—cardiovascular system—hypothyroidism	0.001	0.00687	CbGeAlD
Ketamine—CYP2C9—cardiovascular system—hypothyroidism	0.000994	0.0068	CbGeAlD
Ketamine—CYP2C8—pituitary gland—hypothyroidism	0.000991	0.00678	CbGeAlD
Ketamine—Nausea—Liotrix—hypothyroidism	0.000989	0.0137	CcSEcCtD
Ketamine—PTGS1—heart—hypothyroidism	0.000962	0.00658	CbGeAlD
Ketamine—CYP2B6—gonad—hypothyroidism	0.000911	0.00623	CbGeAlD
Ketamine—PTGS1—cardiovascular system—hypothyroidism	0.000908	0.00621	CbGeAlD
Ketamine—SLC6A2—testis—hypothyroidism	0.000891	0.0061	CbGeAlD
Ketamine—CYP2C8—blood—hypothyroidism	0.000885	0.00606	CbGeAlD
Ketamine—DRD2—testis—hypothyroidism	0.000812	0.00556	CbGeAlD
Ketamine—PTGS1—pituitary gland—hypothyroidism	0.000804	0.0055	CbGeAlD
Ketamine—CYP2B6—adrenal gland—hypothyroidism	0.000794	0.00543	CbGeAlD
Ketamine—CYP2B6—blood—hypothyroidism	0.000794	0.00543	CbGeAlD
Ketamine—CYP2C9—blood—hypothyroidism	0.000786	0.00538	CbGeAlD
Ketamine—DRD2—cerebellum—hypothyroidism	0.00075	0.00513	CbGeAlD
Ketamine—CYP2C8—testis—hypothyroidism	0.000732	0.00501	CbGeAlD
Ketamine—PTGS1—adrenal gland—hypothyroidism	0.000718	0.00491	CbGeAlD
Ketamine—PTGS1—blood—hypothyroidism	0.000718	0.00491	CbGeAlD
Ketamine—PTGS1—thyroid gland—hypothyroidism	0.000693	0.00474	CbGeAlD
Ketamine—CYP2C8—liver—hypothyroidism	0.000692	0.00474	CbGeAlD
Ketamine—PTGS1—female gonad—hypothyroidism	0.000669	0.00458	CbGeAlD
Ketamine—CYP2B6—testis—hypothyroidism	0.000657	0.00449	CbGeAlD
Ketamine—CYP2B6—liver—hypothyroidism	0.000621	0.00425	CbGeAlD
Ketamine—CYP2C9—liver—hypothyroidism	0.000615	0.00421	CbGeAlD
Ketamine—CYP3A4—blood—hypothyroidism	0.000599	0.0041	CbGeAlD
Ketamine—PTGS1—testis—hypothyroidism	0.000594	0.00406	CbGeAlD
Ketamine—ABCB1—adrenal cortex—hypothyroidism	0.000588	0.00402	CbGeAlD
Ketamine—ABCB1—heart—hypothyroidism	0.000569	0.00389	CbGeAlD
Ketamine—ABCB1—cardiovascular system—hypothyroidism	0.000537	0.00367	CbGeAlD
Ketamine—ABCB1—gonad—hypothyroidism	0.000487	0.00333	CbGeAlD
Ketamine—ABCB1—pituitary gland—hypothyroidism	0.000475	0.00325	CbGeAlD
Ketamine—CYP3A4—liver—hypothyroidism	0.000469	0.00321	CbGeAlD
Ketamine—ABCB1—adrenal gland—hypothyroidism	0.000424	0.0029	CbGeAlD
Ketamine—ABCB1—blood—hypothyroidism	0.000424	0.0029	CbGeAlD
Ketamine—DRD2—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00041	0.00176	CbGpPWpGaD
Ketamine—ABCB1—thyroid gland—hypothyroidism	0.00041	0.0028	CbGeAlD
Ketamine—OPRM1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.000409	0.00176	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—VAV3—hypothyroidism	0.000406	0.00174	CbGpPWpGaD
Ketamine—ABCB1—female gonad—hypothyroidism	0.000396	0.00271	CbGeAlD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000371	0.00159	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—CLTC—hypothyroidism	0.000364	0.00157	CbGpPWpGaD
Ketamine—SLC6A2—NRF2 pathway—SLC5A5—hypothyroidism	0.000359	0.00154	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—CLTC—hypothyroidism	0.000355	0.00153	CbGpPWpGaD
Ketamine—ABCB1—testis—hypothyroidism	0.000351	0.0024	CbGeAlD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000346	0.00148	CbGpPWpGaD
Ketamine—TACR1—Peptide ligand-binding receptors—POMC—hypothyroidism	0.000342	0.00147	CbGpPWpGaD
Ketamine—ABCB1—liver—hypothyroidism	0.000332	0.00227	CbGeAlD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00033	0.00142	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00033	0.00142	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000325	0.0014	CbGpPWpGaD
Ketamine—ABCB1—cerebellum—hypothyroidism	0.000324	0.00222	CbGeAlD
Ketamine—OPRD1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.00029	0.00125	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00029	0.00124	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00029	0.00124	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000288	0.00124	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—TRH—hypothyroidism	0.000283	0.00122	CbGpPWpGaD
Ketamine—OPRM1—Opioid Signalling—POMC—hypothyroidism	0.000283	0.00121	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—TRH—hypothyroidism	0.000282	0.00121	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000275	0.00118	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—AVP—hypothyroidism	0.000263	0.00113	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—TRH—hypothyroidism	0.000257	0.0011	CbGpPWpGaD
Ketamine—OPRK1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.000254	0.00109	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—TSHR—hypothyroidism	0.000252	0.00108	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—TSHB—hypothyroidism	0.000252	0.00108	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—TSHB—hypothyroidism	0.000252	0.00108	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—TSHR—hypothyroidism	0.000252	0.00108	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—TRH—hypothyroidism	0.000247	0.00106	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000245	0.00105	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000245	0.00105	CbGpPWpGaD
Ketamine—PTGS1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000243	0.00104	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—VAV3—hypothyroidism	0.000241	0.00103	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000239	0.00102	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—VAV3—hypothyroidism	0.000235	0.00101	CbGpPWpGaD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00023	0.000987	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—TSHB—hypothyroidism	0.000229	0.000985	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—TSHR—hypothyroidism	0.000229	0.000985	CbGpPWpGaD
Ketamine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000229	0.000982	CbGpPWpGaD
Ketamine—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000226	0.000973	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—TSHB—hypothyroidism	0.000221	0.000948	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—TSHR—hypothyroidism	0.000221	0.000948	CbGpPWpGaD
Ketamine—OPRM1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.000215	0.000924	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—TRH—hypothyroidism	0.000209	0.000899	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000208	0.000894	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000195	0.000836	CbGpPWpGaD
Ketamine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000194	0.000832	CbGpPWpGaD
Ketamine—OPRD1—Peptide ligand-binding receptors—POMC—hypothyroidism	0.000193	0.000829	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—TSHR—hypothyroidism	0.000186	0.000801	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—TSHB—hypothyroidism	0.000186	0.000801	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000186	0.000797	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000186	0.000797	CbGpPWpGaD
Ketamine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000185	0.000796	CbGpPWpGaD
Ketamine—SLC6A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000178	0.000766	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CLTC—hypothyroidism	0.000176	0.000755	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—POMC—hypothyroidism	0.000175	0.000751	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—VAV3—hypothyroidism	0.000172	0.000738	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000171	0.000733	CbGpPWpGaD
Ketamine—OPRK1—Peptide ligand-binding receptors—POMC—hypothyroidism	0.000169	0.000727	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—VAV3—hypothyroidism	0.000167	0.000719	CbGpPWpGaD
Ketamine—OPRD1—G alpha (i) signalling events—POMC—hypothyroidism	0.000163	0.000699	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—TRH—hypothyroidism	0.000159	0.000685	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—TRH—hypothyroidism	0.000158	0.000681	CbGpPWpGaD
Ketamine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000158	0.000677	CbGpPWpGaD
Ketamine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000157	0.000674	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—AVP—hypothyroidism	0.000156	0.000669	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—VAV3—hypothyroidism	0.000154	0.000663	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—IYD—hypothyroidism	0.000152	0.000654	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TRH—hypothyroidism	0.000152	0.000653	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—AVP—hypothyroidism	0.000149	0.000639	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—AVP—hypothyroidism	0.000148	0.000637	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—TRH—hypothyroidism	0.000145	0.000622	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000144	0.00062	CbGpPWpGaD
Ketamine—OPRM1—Peptide ligand-binding receptors—POMC—hypothyroidism	0.000143	0.000614	CbGpPWpGaD
Ketamine—OPRK1—G alpha (i) signalling events—POMC—hypothyroidism	0.000143	0.000613	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—TSHB—hypothyroidism	0.000142	0.000611	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—TSHR—hypothyroidism	0.000142	0.000611	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—TSHB—hypothyroidism	0.000141	0.000607	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—TSHR—hypothyroidism	0.000141	0.000607	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—VAV3—hypothyroidism	0.00014	0.000602	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—TRH—hypothyroidism	0.00014	0.000601	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TSHB—hypothyroidism	0.000135	0.000582	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TSHR—hypothyroidism	0.000135	0.000582	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—AVP—hypothyroidism	0.000135	0.00058	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—AVP—hypothyroidism	0.00013	0.000558	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ATP5O—hypothyroidism	0.000129	0.000556	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000129	0.000556	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—TSHB—hypothyroidism	0.000129	0.000555	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—TSHR—hypothyroidism	0.000129	0.000555	CbGpPWpGaD
Ketamine—PTGS1—Biological oxidations—POMC—hypothyroidism	0.000129	0.000554	CbGpPWpGaD
Ketamine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000128	0.000549	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—TRH—hypothyroidism	0.000127	0.000546	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000127	0.000545	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—TSHB—hypothyroidism	0.000125	0.000536	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—TSHR—hypothyroidism	0.000125	0.000536	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—TPO—hypothyroidism	0.000122	0.000523	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—SH2B3—hypothyroidism	0.000121	0.000518	CbGpPWpGaD
Ketamine—OPRM1—G alpha (i) signalling events—POMC—hypothyroidism	0.000121	0.000518	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—TRH—hypothyroidism	0.000118	0.000508	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—IYD—hypothyroidism	0.000116	0.000499	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000115	0.000494	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000113	0.000487	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—TSHR—hypothyroidism	0.000113	0.000486	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—TSHB—hypothyroidism	0.000113	0.000486	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000113	0.000484	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—AVP—hypothyroidism	0.00011	0.000472	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000109	0.00047	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—TRH—hypothyroidism	0.000107	0.000461	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—TSHB—hypothyroidism	0.000105	0.000453	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—TSHR—hypothyroidism	0.000105	0.000453	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000105	0.000451	CbGpPWpGaD
Ketamine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000104	0.000446	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CLTC—hypothyroidism	9.9e-05	0.000425	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—POMC—hypothyroidism	9.88e-05	0.000425	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ATP5O—hypothyroidism	9.87e-05	0.000424	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—POMC—hypothyroidism	9.85e-05	0.000423	CbGpPWpGaD
Ketamine—CYP2B6—Biological oxidations—POMC—hypothyroidism	9.84e-05	0.000423	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—IYD—hypothyroidism	9.83e-05	0.000422	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	9.59e-05	0.000412	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—TSHB—hypothyroidism	9.57e-05	0.000411	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—TSHR—hypothyroidism	9.57e-05	0.000411	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—TPO—hypothyroidism	9.28e-05	0.000399	CbGpPWpGaD
Ketamine—DRD2—G alpha (i) signalling events—POMC—hypothyroidism	9.14e-05	0.000393	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—AVP—hypothyroidism	9.06e-05	0.000389	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—POMC—hypothyroidism	8.98e-05	0.000386	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—TRH—hypothyroidism	8.96e-05	0.000385	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—PRL—hypothyroidism	8.95e-05	0.000385	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—VAV3—hypothyroidism	8.7e-05	0.000374	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CLTC—hypothyroidism	8.68e-05	0.000373	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—POMC—hypothyroidism	8.64e-05	0.000371	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—IYD—hypothyroidism	8.57e-05	0.000368	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TRH—hypothyroidism	8.55e-05	0.000368	CbGpPWpGaD
Ketamine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	8.42e-05	0.000362	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AVP—hypothyroidism	8.38e-05	0.00036	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ATP5O—hypothyroidism	8.36e-05	0.000359	CbGpPWpGaD
Ketamine—CYP2C8—Biological oxidations—POMC—hypothyroidism	8.33e-05	0.000358	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—AVP—hypothyroidism	8.33e-05	0.000358	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—VAV3—hypothyroidism	8.28e-05	0.000356	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—TRH—hypothyroidism	8.13e-05	0.000349	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—IYD—hypothyroidism	8e-05	0.000344	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—TSHB—hypothyroidism	7.98e-05	0.000343	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—TSHR—hypothyroidism	7.98e-05	0.000343	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AVP—hypothyroidism	7.98e-05	0.000343	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—VAV3—hypothyroidism	7.9e-05	0.000339	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—TPO—hypothyroidism	7.86e-05	0.000338	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TSHR—hypothyroidism	7.62e-05	0.000328	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TSHB—hypothyroidism	7.62e-05	0.000328	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—VAV3—hypothyroidism	7.62e-05	0.000328	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AVP—hypothyroidism	7.61e-05	0.000327	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TRH—hypothyroidism	7.5e-05	0.000322	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AVP—hypothyroidism	7.35e-05	0.000316	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CLTC—hypothyroidism	7.34e-05	0.000315	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—POMC—hypothyroidism	7.3e-05	0.000314	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ATP5O—hypothyroidism	7.28e-05	0.000313	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	7.28e-05	0.000313	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	7.27e-05	0.000312	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—TSHB—hypothyroidism	7.25e-05	0.000311	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—TSHR—hypothyroidism	7.25e-05	0.000311	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—VAV3—hypothyroidism	6.92e-05	0.000297	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—TPO—hypothyroidism	6.85e-05	0.000294	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ATP5O—hypothyroidism	6.8e-05	0.000292	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SH2B3—hypothyroidism	6.8e-05	0.000292	CbGpPWpGaD
Ketamine—CYP2C9—Biological oxidations—POMC—hypothyroidism	6.78e-05	0.000291	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TSHB—hypothyroidism	6.69e-05	0.000287	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TSHR—hypothyroidism	6.69e-05	0.000287	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AVP—hypothyroidism	6.67e-05	0.000287	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—VAV3—hypothyroidism	6.44e-05	0.000277	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	6.42e-05	0.000276	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—TPO—hypothyroidism	6.4e-05	0.000275	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TRH—hypothyroidism	6.34e-05	0.000272	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AVP—hypothyroidism	6.21e-05	0.000267	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SH2B3—hypothyroidism	5.96e-05	0.000256	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	5.93e-05	0.000255	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—VAV3—hypothyroidism	5.85e-05	0.000251	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TSHR—hypothyroidism	5.65e-05	0.000243	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TSHB—hypothyroidism	5.65e-05	0.000243	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AVP—hypothyroidism	5.64e-05	0.000242	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—TSHB—hypothyroidism	5.63e-05	0.000242	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—POMC—hypothyroidism	5.57e-05	0.000239	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CLTC—hypothyroidism	5.56e-05	0.000239	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—POMC—hypothyroidism	5.53e-05	0.000238	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—POMC—hypothyroidism	5.3e-05	0.000228	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—IYD—hypothyroidism	5.28e-05	0.000227	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IGF1—hypothyroidism	5.1e-05	0.000219	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.07e-05	0.000218	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—POMC—hypothyroidism	5.06e-05	0.000217	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PRL—hypothyroidism	5.04e-05	0.000217	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SH2B3—hypothyroidism	5.04e-05	0.000216	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3C2A—hypothyroidism	5.02e-05	0.000216	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.95e-05	0.000213	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	4.88e-05	0.00021	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—POMC—hypothyroidism	4.88e-05	0.00021	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TRH—hypothyroidism	4.8e-05	0.000206	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AVP—hypothyroidism	4.7e-05	0.000202	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VAV3—hypothyroidism	4.66e-05	0.0002	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AVP—hypothyroidism	4.49e-05	0.000193	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ATP5O—hypothyroidism	4.49e-05	0.000193	CbGpPWpGaD
Ketamine—CYP3A4—Biological oxidations—POMC—hypothyroidism	4.47e-05	0.000192	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—VAV3—hypothyroidism	4.43e-05	0.000191	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—POMC—hypothyroidism	4.43e-05	0.00019	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PRL—hypothyroidism	4.42e-05	0.00019	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—TSHB—hypothyroidism	4.3e-05	0.000185	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TSHB—hypothyroidism	4.28e-05	0.000184	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TSHR—hypothyroidism	4.28e-05	0.000184	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AVP—hypothyroidism	4.27e-05	0.000184	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—TPO—hypothyroidism	4.22e-05	0.000181	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—SLC5A5—hypothyroidism	4.22e-05	0.000181	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—POMC—hypothyroidism	4.13e-05	0.000177	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VAV3—hypothyroidism	4.09e-05	0.000176	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	3.99e-05	0.000171	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AVP—hypothyroidism	3.94e-05	0.000169	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3C2A—hypothyroidism	3.83e-05	0.000165	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SH2B3—hypothyroidism	3.82e-05	0.000164	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—POMC—hypothyroidism	3.75e-05	0.000161	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PRL—hypothyroidism	3.74e-05	0.000161	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—TSHB—hypothyroidism	3.64e-05	0.000156	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VAV3—hypothyroidism	3.46e-05	0.000149	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AVP—hypothyroidism	3.33e-05	0.000143	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	3.24e-05	0.000139	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—SLC5A5—hypothyroidism	3.22e-05	0.000138	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.2e-05	0.000138	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—TSHB—hypothyroidism	3.17e-05	0.000136	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—POMC—hypothyroidism	3.13e-05	0.000134	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—POMC—hypothyroidism	2.99e-05	0.000128	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—TSHB—hypothyroidism	2.96e-05	0.000127	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IGF1—hypothyroidism	2.87e-05	0.000123	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—POMC—hypothyroidism	2.84e-05	0.000122	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PRL—hypothyroidism	2.83e-05	0.000122	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3C2A—hypothyroidism	2.83e-05	0.000121	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—SLC5A5—hypothyroidism	2.72e-05	0.000117	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	2.64e-05	0.000113	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VAV3—hypothyroidism	2.62e-05	0.000113	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—POMC—hypothyroidism	2.62e-05	0.000113	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.6e-05	0.000112	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AVP—hypothyroidism	2.52e-05	0.000108	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IGF1—hypothyroidism	2.52e-05	0.000108	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SLC5A5—hypothyroidism	2.37e-05	0.000102	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SLC5A5—hypothyroidism	2.22e-05	9.53e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—POMC—hypothyroidism	2.21e-05	9.51e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—POMC—hypothyroidism	2.21e-05	9.48e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IGF1—hypothyroidism	2.13e-05	9.15e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—TSHB—hypothyroidism	1.95e-05	8.39e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.74e-05	7.48e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—POMC—hypothyroidism	1.68e-05	7.23e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—POMC—hypothyroidism	1.68e-05	7.21e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF1—hypothyroidism	1.61e-05	6.93e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.46e-05	6.28e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—POMC—hypothyroidism	1.43e-05	6.12e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—POMC—hypothyroidism	1.24e-05	5.33e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—POMC—hypothyroidism	1.16e-05	4.98e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—POMC—hypothyroidism	7.65e-06	3.29e-05	CbGpPWpGaD
